GlassScriptPhysician profile
Imran Akhtar
NPI 1063892560
$9,374.07
in general payments reported to CMS, 2019-2025
23 companies · $1,692 in 2025
The $1,692 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,024 · 2020: $457 · 2021: $1,619 · 2022: $554 · 2023: $629 · 2024: $400 · 2025: $1,692.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,551 · Travel and Lodging: $1,169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,550.58 |
| Travel and Lodging | $1,169.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,120.92 | 2019-2025 | Gravity Synchfix, Axsos, Variax |
| Pylant Medical | $2,074.00 | 2019 | |
| Zimmer Biomet Holdings, INC. | $1,474.28 | 2025 | G7, Avenir, Persona |
| Smith+Nephew, INC. | $942.33 | 2020-2025 | Redapt, Trigen Intertan, Accord |
| Depuy Synthes Sales INC. | $722.37 | 2021-2025 | Attune, Actis, Velys |
| Si-Bone, INC. | $655.34 | 2019 | |
| Pacira Therapeutics, INC. | $514.95 | 2020-2021 | |
| Boston Scientific Corporation | $223.54 | 2021-2024 | Coveredge 32 |
| Aesculap Implant Systems, LLC | $173.37 | 2020 | |
| Bioventus LLC | $79.11 | 2020-2023 | Durolane |
| Ferring Pharmaceuticals INC. | $54.62 | 2022-2023 | Euflexxa |
| Endo USA, INC. | $46.48 | 2025 | Xiaflex |
| Medical Device Business Services, INC. | $43.35 | 2021-2022 | |
| Innovation Technologies INC | $40.92 | 2023 | Irrisept |
| Nevro Corp. | $37.67 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $34.92 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $33.40 | 2021-2024 | Iovera, Zilretta, Exparel |
| Integra Lifesciences Corporation | $32.94 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Heraeus Medical, LLC. | $21.09 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $20.95 | 2025 | Dysport |
| Dynasplint Systems INC. | $19.05 | 2023 | Dynasplint |
| Skeletal Dynamics INC | $7.03 | 2025 | Ijs, Geminus, Implate |
| Spr Therapeutics, INC | $1.44 | 2024 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Imran Akhtar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.